Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


PP2A inhibitor
ALX-270-063-M025 25 mg 81.00 USD
ALX-270-063-M100 100 mg 260.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: BML-PR105

Potent protein phosphatase 2A (PP2A) inhibitor. At higher concentrations, also inhibits protein phosphatase 1 (PP1).

Product Details

Alternative Name:Hexahydro-3a,7a-dimethyl-4,7-epoxyisobenzo-furan-1,3-dione
MI:14: 1752
Purity:≥98% (GC)
Appearance:White to off-white solid.
Solubility:Soluble in DMSO or 100% ethanol.
Shipping:Ambient Temperature
Long Term Storage:Ambient
Handling:Protect from light.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

MAP kinases associate with high molecular weight multiproteincomplexes: C.J. Bequette, et al.; J. Exp. Bot. 69, 643 (2018), Abstract; Full Text
PP2A inhibitors suppress migration and growth of PANC-1 pancreatic cancer cells through inhibition on the Wnt/β-catenin pathway by phosphorylation and degradation of β-catenin: M.Y. Wu, et al.; Oncol Rep. 32, 513 (2014), Abstract; Full Text
Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues: Y.-M. Li, et al.; Biochem. Pharmacol. 46, 1435 (1993), Abstract;
Cantharidin-binding protein: identification as protein phosphatase 2A: Y.-M. Li & J.E. Casida; PNAS 89, 11867 (1992), Abstract;
Partial characterization of specific cantharidin binding sites in mouse tissues: M.J. Graziano, et al.; Mol. Pharmacol. 33, 706 (1988), Abstract;

Related Literature

Download as PDF

All new literature pieces